SUPPORT for Alzheimer’s Disease Research and Treatment

 

In this day and age, with Canadians living longer, generally healthier lives, there is one dark cloud which shadows the silver lining of improved longevity: Alzheimer’s Disease.

With over 500,000 people living with Alzheimer’s Disease in Canada, the chances are great that you know someone with the disease. In the United States, it is the sixth cause of death in adults, and the ONLY disease which currently has no effective medications which either slow or cure the disease process.

Many of us, myself included, assume that becoming a little forgetful is just a natural part of aging. But I have had to come to terms with my mother having some type of dementia, in all likelihood it could have been Alzheimer’s, although there is no current test that absolutely supports an affirmative diagnosis while the patient is living. As was true for my mother, Alzheimer’s Disease is an actual disease process that will eventually claim its victim. This disease is far beyond one’s forgetting where they placed their car keys. Those who suffer from Alzheimer’s will eventually lose control of their bodily functions, and may continue to live past the time they recognize anyone they love or understand any events occurring around them.

The Alzheimer Disease Society of Canada was formed in 1978, with the mission of educating the public that this disease is NOT a natural consequence of aging, to raise funds for research, and to improve the treatment of patients and support of their care-givers. It has awarded over $30 million dollars in research, making Canada a world leader in the advancement of knowledge and understanding of this complicated illness (Alzheimer’s Disease Society of Canada).

You can read more about the 10 Warning Signs, participate in local fund-raising events and improve the care of your loved one who may be in the early stages of this disease. We know now that early intervention can slow the progression of symptoms, and offer the patient and their family and friends some respite from the suffering they all face. Although there is no cure, and patients with this disease cannot now enjoy the promise of a cure, through our combined efforts, hopefully in our own lifetimes, medications and treatments will be formulated to turn this once terminal disease into a chronic assortment of symptoms which can be tolerated until life ends for some other reason.

Please join us in support of the Alzheimer’s Disease Society of Canada by finding out more on their website: www.alzheimer.ca.

I thank you.

Dr. Rodney Shainbom